tradingkey.logo
怜玢
マヌケット
ニュヌス
分析
ツヌル
株匏スクリヌナヌ


English
繁䜓䞭文
à¹„àž—àž¢
Tiếng việt
简䜓䞭文
Español
Português
Deutsch
한국얎
日本語

tradingkey.logo
怜玢



Rapport Therapeutics Inc

RAPP
りォッチリストに远加
39.390USD
-2.280-5.47%
終倀 07/01, 16:00ET15分遅れの株䟡
1.88B時䟡総額
損倱額盎近12ヶ月PER

Rapport Therapeutics Inc

39.390
-2.280-5.47%
抂芁
金融
ディスカッション
分析
䌁業名
プロフィヌル収益株䞻統蚈䌁業情報

抂芁

金融

ディスカッション

分析

䌁業名

プロフィヌル収益株䞻統蚈䌁業情報

株䞻

曎新時刻: Mon, May 11
曎新時刻: Mon, May 11
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Third Rock Ventures, LLC
15.48%
Fidelity Management & Research Company LLC
14.87%
ARCH Venture Partners
7.80%
Capital International Investors
7.11%
Cormorant Asset Management, LP
6.33%
他の
48.41%
株䞻統蚈
株䞻統蚈
比率
Third Rock Ventures, LLC
15.48%
Fidelity Management & Research Company LLC
14.87%
ARCH Venture Partners
7.80%
Capital International Investors
7.11%
Cormorant Asset Management, LP
6.33%
他の
48.41%
皮類
株䞻統蚈
比率
Investment Advisor
44.45%
Venture Capital
31.60%
Investment Advisor/Hedge Fund
12.72%
Hedge Fund
12.70%
Individual Investor
4.65%
Research Firm
4.37%
Private Equity
1.41%
Bank and Trust
0.43%
Pension Fund
0.15%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
264
57.38M
119.98%
+6.40M
2025Q4
222
49.73M
104.33%
+9.58M
2025Q3
166
42.95M
90.12%
+1.16M
2025Q2
154
43.38M
118.86%
+3.70M
2025Q1
149
47.96M
131.36%
+9.87M
2024Q4
117
46.27M
126.51%
+9.23M
2024Q3
91
39.09M
106.87%
+12.18M
2024Q2
48
37.49M
102.49%
+37.49M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Third Rock Ventures, LLC
8.10M
17%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
6.92M
14.51%
+1.44M
+26.35%
Sep 30, 2025
ARCH Venture Partners
3.73M
7.82%
--
--
Sep 30, 2025
Capital International Investors
3.40M
7.14%
+800.00K
+30.74%
Sep 30, 2025
Cormorant Asset Management, LP
3.19M
6.7%
+251.60K
+8.56%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.42M
2.97%
+354.67K
+33.41%
Sep 30, 2025
Sofinnova Investments, Inc
1.95M
4.09%
-48.02K
-2.41%
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.63M
3.43%
+397.43K
+32.18%
Sep 30, 2025
Johnson & Johnson Innovation-JJDC, Inc.
1.78M
3.74%
-713.53K
-28.56%
Sep 30, 2025
Baker Bros. Advisors LP
1.55M
3.25%
+997.00K
+181.24%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Tue, Dec 2
曎新時刻: Tue, Dec 2
銘柄名
比率
Virtus LifeSci Biotech Clinical Trials ETF
1.76%
iShares Neuroscience and Healthcare ETF
0.84%
ALPS Medical Breakthroughs ETF
0.43%
Invesco Nasdaq Biotechnology ETF
0.1%
iShares Micro-Cap ETF
0.1%
ProShares Ultra Nasdaq Biotechnology
0.1%
Avantis US Small Cap Equity ETF
0.06%
iShares Biotechnology ETF
0.06%
Vanguard US Momentum Factor ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
詳现を芋る
Virtus LifeSci Biotech Clinical Trials ETF
比率1.76%
iShares Neuroscience and Healthcare ETF
比率0.84%
ALPS Medical Breakthroughs ETF
比率0.43%
Invesco Nasdaq Biotechnology ETF
比率0.1%
iShares Micro-Cap ETF
比率0.1%
ProShares Ultra Nasdaq Biotechnology
比率0.1%
Avantis US Small Cap Equity ETF
比率0.06%
iShares Biotechnology ETF
比率0.06%
Vanguard US Momentum Factor ETF
比率0.04%
iShares Russell 2000 Value ETF
比率0.03%